Lançon J P, Caillard B, Obadia J F, Pillet M, Leblanc-Beaufils C, Le Bloch Y
Département d'anesthésie-réanimation, CHRU du Bocage, Dijon.
Arch Mal Coeur Vaiss. 1991 Nov;84(11):1575-9.
Milrinone is an inotropic agent of the phosphodiesterase inhibitor family. In common with all molecules of this class it has both positive inotropic and vasodilator effects. The haemodynamic effects of 3 dosages of milrinone were studied in 25 patients with low output states after open heart surgery. The low cardiac output was defined as a cardiac index of less than 2.5/min/m2 and pulmonary capillary pressures greater than 8 mmHg. Milrinone was administered as a bolus of 50 micrograms/kg/min over 10 minutes followed by a continuous infusion for at least 12 hours. Six patients were given 0.375 micrograms/kg/min, six patients 0.5 micrograms/kg/min, and 13 patients 0.75 g/kg/min. A significant increase in cardiac index was observed but without any difference between the 3 groups. The heart rate and stroke volumes were increased. There was a mild reduction in systemic blood pressure with a decrease in systemic arterial resistances which returned to almost normal values. Left and right filling pressures did not decrease significantly from the initial values until the end of the bolus injection. Indirect measurements of myocardial oxygen consumption showed an increase in this parameter. There were no changes in blood gas concentrations. The treatment was stopped in only one patient because of peripheral vasodilation. Two patients developed supraventricular tachycardia of no consequence. Milrinone may therefore be proposed as treatment of first intention of low cardiac output states after open heart surgery. It is associated with a mild vasodilatory effect. Improved myocardial function is observed providing attention is paid to vascular filling. None of the maintenance doses used after the bolus injection was shown to be more effective than the others.
米力农是磷酸二酯酶抑制剂家族的一种正性肌力药物。与该类所有分子一样,它具有正性肌力和血管舒张作用。在25例心脏直视手术后低心排血量状态的患者中研究了3种剂量米力农的血流动力学效应。低心排血量定义为心脏指数小于2.5/min/m²且肺毛细血管压大于8 mmHg。米力农以50微克/千克/分钟的剂量静脉推注10分钟,随后持续输注至少12小时。6例患者给予0.375微克/千克/分钟,6例患者给予0.5微克/千克/分钟,13例患者给予0.75微克/千克/分钟。观察到心脏指数显著增加,但3组之间无差异。心率和每搏量增加。全身血压轻度降低,全身动脉阻力降低,几乎恢复到正常水平。左、右充盈压在推注结束前与初始值相比无显著下降。心肌氧耗的间接测量显示该参数增加。血气浓度无变化。仅1例患者因外周血管扩张而停止治疗。2例患者出现无临床意义的室上性心动过速。因此,米力农可作为心脏直视手术后低心排血量状态的首选治疗药物。它伴有轻度血管舒张作用。观察到心肌功能改善,前提是注意血管充盈。推注后使用的维持剂量均未显示比其他剂量更有效。